Mersana

is a Massachusetts-based biopharmaceutical company that researches and develops antibody-drug conjugates for the treatment of cancer...
Read more
Mersana President & CEO: Martin Huber

President & CEO

Martin Huber

CEO Approval Rating

82/100

Annual Revenue
$40.5M
Employees
150
Funding
$289.1M

Mersana Competitors

1Daiichi Sankyo
2ImmunoGen
3Gilead
4CytomX
5Igenica
6AnaptysBio
7ADC Therapeutics
8Paragon Gene
9ADC Bio
10Meditope

Trending Companies